(Q35067737)
Statements
Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer (English)
Timothy M Pawlik
Ralph H Hruban
Christopher L Wolfgang
John L Cameron
Richard D Schulick
Barish H Edil
Ross C Donehower
Daniel A Laheru
Laura D Wood
Michael A Choti
Amanda L Blackford
Ana De Jesus-Acosta
Amy Hacker-Prietz
Katherine Y Fan
Susannah Ellsworth
Joseph M Herman
Aaron T Wild
Lei Zheng
1 reference
1 reference
1 reference